V116

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for V116, covering 2022-08-02 to 2025-02-26. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of V116 in Adults With Increased Risk for Pneumococcal Disease (V116-008) [Phase 3]